Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2018 Nov 13;8:16770. doi: 10.1038/s41598-018-35169-x

IL-17A expression in the adenoid tissue from children with sleep disordered breathing and its association with pneumococcal carriage

Chien-Chia Huang 1,2, Pei-Wen Wu 1,3, Chyi-Liang Chen 4, Chun-Hua Wang 5, Ta-Jen Lee 1, Chi-Neu Tsai 2, Cheng-Hsun Chiu 4,6,✉
PMCID: PMC6233154  PMID: 30425273

Abstract

Tonsil and adenoid-tissue hypertrophy (AH) is the most common cause of pediatric sleep-disordered breathing (SDB), with AH possibly initiated by repeated exposure to infectious agents or allergens. Here, we evaluated IL-17A activity in adenoid tissue from children with SDB and its association with AH and pneumococcal carriage. Thirty-five children (aged 3–12 years) with SDB and receiving adenoidectomy and tonsillectomy were enrolled. During surgery, nasopharyngeal carriage was determined by bacterial culture and multiplex PCR via nasopharyngeal swab, and adenoid samples were collected. IL-17A and associated cytokine expression was evaluated by real-time PCR and western blotting. The mRNA analysis showed that IL-17A level, IL-17A:IL-10 ratio, and RAR-related orphan receptor-γt:forkhead box P3 ratio were significantly higher in adenoid tissues with AH, as were IL-17A level and IL-17A:IL-10 ratio in adenoid tissues with pneumococcal carriage. Additionally, pneumococcal carriage was more common in nasopharyngeal adenoids from patients without AH than those with AH. IL-17A was upregulated in adenoid tissues from patients with AH and with pneumococcal carriage. These results suggested that pneumococcal carriage initiates an IL-17A-mediated immune response in nasopharyngeal adenoids, which might be associated with AH in patients with SDB.

Introduction

Obstructive sleep-disordered breathing (SDB) is a clinical condition associated with breathing problems due to an obstruction of the upper airways when sleeping and ranges in severity from simple snoring to obstructive sleep apnea syndrome (OSAS)1,2. SDB is common in the pediatric population, with an estimated prevalence of simple snoring in children at ~8% to ~27% and of OSAS at ~1% to ~5%3,4. Pediatric SDB can significant impact quality of life and link to behavioral problems, including hyperactivity, emotional irritability, and aggression, as well as failure to thrive if untreated5–7.

Hypertrophy of the tonsils and adenoid tissue (AH) is considered among the most common etiologies of SDB in children2,8 and causes narrowing of the upper airway, potentially leading to partial or complete obstruction of the airway particularly during sleeping as the pharyngeal muscle relaxes. As a result, tonsillectomy and adenoidectomy are considered the treatments of choice for most cases of pediatric SDB8,9. Moreover, regrowth of adenoid tissue is a common reason for residual or recurrent disease10. It is currently believed that AH is initiated by repeated exposure to infectious agents or allergens; however, the exact mechanism associated with the selective susceptibility of some children who have developed AH remains unknown.

Nasopharyngeal adenoids are a part of Waldeyer’s ring and represent a mass of lymphoid tissue located in a critical position in the upper respiratory tract and serve as the first line of immune defense and important effectors in both mucosal and systemic adaptive immunity11. In the lymphoid tissue of the adenoid, B lymphocytes represent ~65% of total lymphocytes, with the remaining comprising either T lymphocytes or plasma cells12. Among these, helper T (Th) cells play a critical role in immune protection based on their ability to activate B cells to produce antibodies and recruit various leukocytes to sites of infection and inflammation13. Th cells can differentiate into parallel types of effector CD4+ T cells (Th1, Th2, and Th17 subsets) to protect against different kinds of pathogens by stimulating the production of different cytokines and other soluble and cell-bound products and can function as immune effectors to eliminate infected cells14. Regulatory T (Treg) cells expressing the transcription factor forkhead box P3 (Foxp3) play an important regulatory role during infections, diminish immune responses to microbial pathogens, and prevent inflammation-related local-tissue damage or autoimmunity, but are also capable of contributing to infection chronicity15,16.

Streptococcus pneumoniae (pneumococcus) is among the most frequent colonizer of the pediatric nasopharynx and acts as a prerequisite of infectious diseases, including local mucosal diseases of the otitis media, sinusitis, and invasive diseases associated with pneumonia, bacteremia, and meningitis17,18. Recent evidence suggests an important role of Th17/Treg cells and their associated cytokines in the response to pneumococcal colonization in human nasopharyngeal adenoids15,19. Th17 cells expressing the transcription factor RAR-related orphan receptor-γt (RORγt) and its signature cytokine IL-17A play an important role in host defense against infection, including mucosal clearance of pneumococcal colonization20–22. However, Treg cells in the adenoid are also reportedly associated with persistent pneumococcal carriage in the nasopharynx15,20. Therefore, the relationship between Th17/Treg-mediated immune response, pneumococcal carriage, and AH remains incompletely understood. Here, we tested the hypothesis that Th17 cells and the associated immune response might play a role in S. pneumoniae scavenging and AH development by evaluating IL-17A expression in adenoid tissue from children with SDB and its association with AH and pneumococcal carriage.

Methods

Patients

Between April 2015 and December 2016, we prospectively recruited patients with SDB that were being managed at our respective Otolaryngology Departments (Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan). The inclusion criteria included the following pediatric patients: (1) aged 3 to 12 years; (2) exhibiting significant symptoms of snoring that disrupted the quality of sleep or daily activities, and (3) who planned to undergo adenoidectomy and tonsillectomy. Exclusion criteria included the following: (1) receipt of antibiotic therapy within the previous 4 weeks; (2) congenital anomalies to include cleft palate, Down syndrome, congenital heart disease, and craniofacial anomalies; or (3) major medical disorders, such as diabetes, nephrotic disease, autoimmune disorders, immunodeficiency, malignancy, and other chronic illnesses.

SDB was diagnosed based on clinical symptoms, such as sleep disturbances, physical symptoms, emotional symptoms, daytime function, and polysomnography, if available. The size of nasopharyngeal adenoids according to skull lateral-view radiography, allergy profiles, symptom scores according to OSA-18 questionnaire23, and vaccination history for pneumococcal conjugate vaccine (PCV) were obtained before surgery. Adenoid:Nasopharynx (A:N) ratio was measured by lateral cephalometry, as described by Fujioka et al.24 and was calculated as the ratio of the distance between the outermost point of the anterior convexity of the adenoid shadow and the straight part of the anterior margin of the basicocciput to the distance between sphenobasioccipital synchondrosis and the posterior end of the hard palate (Fig. 1).

Figure 1.

Figure 1

Open in a new tab

Adenoid: Nasopharynx ratio was measured by lateral cephalometry and was calculated as the ratio of the distance between the outermost point of anterior convexity of the adenoid shadow (A) and the straight part of the anterior margin of the basicocciput (P) to the distance between sphenobasioccipital synchondrosis and the posterior end of the hard palate (N).

All patients were followed clinically for at least 6 months after surgery. All participants and/or their legal guardians provided informed consent prior to being enrolled in this study. The Institutional Review Board of Chang Gung Memorial Hospital approved the study (IRB number: 103–4773B). All research was performed in accordance with the relevant guidelines and regulations.

Detection of nasopharyngeal colonization

Bacterial cultures were obtained using sterile swabs from the surface of the nasopharyngeal adenoid before removal of adenoid tissue during surgery. Swabs were transported to the laboratory in Amies transport medium (Copan Italia, Brescia, Italy) and placed on blood agar plates, eosin methylene blue plates, and Columbia colistin-nalidixic acid agar biplates and cultured at 37 °C for 48 h. S. pneumoniae, Haemophilus influenzae, Moraxella cattarrhalis, and Staphylococcus aureus isolates were identified by colony morphology and conventional methods of determination25.

Another nasopharyngeal swab was sent to the laboratory for S. pneumoniae serotyping, which was determined by multiplex PCR, as previous described26. Briefly, nucleic acids from each nasopharyngeal swab were extracted using a QIAamp genomic DNA kit (Qiagen, Valencia, CA, USA) according to manufacturer protocol, and the extracted DNA suspension was kept frozen at −70 °C until further use. Thirty five serotype-specific primer pairs were designed, as previously described26. A primer pair targeting cpsA found in all 90 known pneumococcal serotypes was used as the positive control. PCR conditions were 94 °C for 4 min, 30 cycles of 94 °C for 45 s, 54 °C for 45 s, and 65 °C for 2 min 30 s. PCR products were analyzed by gel electrophoresis on a 1.4% agarose gel at 120 V for 45 min, followed by staining with ethidium bromide and visualization by ultraviolet transillumination. All oligonucleotide primer sequences have been published by the Centers for Disease Control (Atlanta, GA, USA) and are available (http://www.cdc.gov/ncidod/biotech/strep/pcr.htm).

Specimen collection and processing

Adenoid tissues were obtained by adenoidectomy. Adenoidal specimens were rinsed in phosphate-buffered saline (pH 7.6), stored at −70 °C, and then processed for real-time PCR and western blot.

RNA extraction and reverse transcription

Total RNA was isolated from adenoid tissue using the RNeasy mini kit (Qiagen) according to manufacturer instructions. Extracted RNA was quantified using a NanoDrop machine (Thermo Scientific, Barrington, Ill, USA) and stained with ethidium bromide to determine RNA integrity. Reverse transcription was performed with random hexamer primers using the high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA).

Real-time PCR to determine cytokine and transcription-factor expression

Real-time PCR was performed by TaqMan assay using primers specific for target genes [Supplemental Table S1] and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) on an Applied Biosystems 7500 fast real-time PCR system (Applied Biosystems). The amplification conditions comprised an initial incubation at 95 °C for 10 min, followed by 45 cycles of 95 °C for 10 s, 60 °C for 20 s, and 72 °C for 10 s, with a final cooling period at 40 °C. Each sample was run in triplicate in separate tubes to permit quantification of gene expression. The mean threshold cycle (Ct) values were normalized to GAPDH, and relative mRNA levels of target genes were analyzed by the 2−∆∆Ct method.

Western blot analysis of IL-17A

Total protein was prepared using 1% IGEPAL lysis buffer (Sigma-Aldrich. St. Louis, MO, USA). Cellular proteins (10 μg) were fractionated by SDS-PAGE, electroblotted onto polyvinylidene difluoride membranes, and antibodies against IL-17A (1:500; Santa Cruz Biotechnology, Dallas, TX, USA) and β-actin (1:20,000; Millipore, Billerica, MA, USA) were used to assess differences in protein levels by enhanced chemiluminescence. Protein bands were visualized using a gel documentation system (Alpha Innotech, San Leandro, CA. USA). Relevant band intensities were quantified by densitometric analysis and normalized to β-actin.

Statistical analysis

Data were presented as the mean ± standard deviation and statistically analyzed using GraphPad Prism 5 software (GraphPad Software, San Diego, CA, USA). Categorical data were compared using the Chi-squared test or Fisher’s exact test, as appropriate. Continuous variables were analyzed by the Mann–Whitney U test when comparing between two groups. Correlation was determined using the Spearman’s correlation coefficient. Statistical significance was set at p < 0.05. The power calculated from the difference between the primary outcomes in the study groups was 83.7%.

Results

Clinical characteristics of the study population

A total of 35 consecutive SDB patients who received adenoidectomy and tonsillectomy during the study period were enrolled. Twenty six were presented with AH (SDBwAH) defined by an A:N ratio >60%. The remaining nine patients were grouped as SDB without AH (SDBsAH; A:N ratio <50%). Table 1 summarizes the clinical characteristics of the participants. There were no statistical differences between the two groups, except for the A:N ratio.

Table 1.

Clinical characteristics of study populations.

SDBwAH SDBsAH p value†
Case number 26 9
Age (year) 6.7 ± 2.1 7.4 ± 2.4 ns
Male: Female 20: 6 8: 1 ns
BMI 17.6 ± 4.9 17.5 ± 2.6 ns
Atopy, n (%) 13 (50.0) 4 (44.4) ns
PCV 7, n (%) 5 (19.2) 0 (0) ns
PCV 13, n (%) 14 (53.8) 7 (77.8) ns
OSA-18 68.0 ± 18.3 66.1 ± 17.8 ns
WBC (1000/dL) 8.3 ± 2.1 8.9 ± 2.1 ns
Eosinophil (%) 4.6 ± 3.8 3.7 ± 3.5 ns
Total IgE 377.3 ± 716.7 242.8 ± 184.2 ns
A:N ratio (%) 80.5 ± 7.9 46.6 ± 1.9 <0.001**
Open in a new tab

Data was represented as the mean ± standard deviation.

†Categorical variables were compared using the Chi-squared test or Fisher’s exact test, as appropriate, and continuous variables were analyzed by the Mann–Whitney U test between the two groups.

**p < 0.01.

SDBwAH, sleep-disordered breathing with adenoid hypertrophy; SDBsAH, sleep-disordered breathing without adenoid hypertrophy; BMI, body mass index; PCV, pneumococcal conjugate vaccine; OSA-18, Obstructive Sleep Apnea-18 questionnaire; A:N ratio, adenoid:nasopharynx ratio; ns: not significant.

Cytokine and transcription-factor mRNA expression in nasopharyngeal adenoids

The mRNA-expression levels of IL-17A, the IL-17A:IL-10 ratio, and the RORγt/Foxp3 ratio were significantly greater in adenoid tissues from SDBwAH patients as compared with those from SDBsAH patients (Fig. 2a,e,f). There was no differences in IL-12A (Th1-driven cytokine), IL-5 (Th2-driven cytokine) and IL-10 (Treg-driven cytokine) mRNA levels between SDBwAH and SDBsAH patients (Fig. 2b–d).

Figure 2.

Figure 2

Open in a new tab

Comparison of IL-17A (a) IL-12A (b) IL-5 (c) and IL-10 (d) mRNA levels, as well as the IL-17:IL-10 (e) and RORγt/Foxp3 (f) ratios, in adenoid tissues between SDBwAH (n = 26) and SDBsAH (n = 9) patients according to real-time PCR. IL-17A mRNA levels and IL-17:IL-10 and RORγt/Foxp3 ratios were significantly upregulated in SDBwAH patients relative to SDBsAH patients. *p < 0.05 according to Mann-Whitney U test.

Pneumococcal carriage was more common in nasopharyngeal adenoids from patients without AH than in those with AH (Fig. 3a). Comparison of AH tissues positive and negative for pneumococcal carriage showed significantly higher levels of IL-17A (Fig. 3b) and IL-17A:IL-10 (Fig. 3c) mRNA in the 11 AH tissues positive for pneumococcal carriage than the other 15 AH tissues negative for pneumococcal carriage. Furthermore, adenoid tissues positive for S. pneumoniae as detected by conventional culture (either with or without positive PCR results) showed significantly higher levels of IL-17A mRNA than those only positive for S. pneumoniae according to multiplex PCR (Fig. 3d).

Figure 3.

Figure 3

Open in a new tab

Streptococcus pneumoniae carriage was more common in nasopharyngeal adenoids of patients without AH (a). Significantly higher levels of IL-17A (b) mRNA levels and IL-17:IL-10 (c) ratio were observed in adenoid tissue positive for pneumococcal carriage (n = 11) than that negative for pneumococcal carriage (n = 15) in patients with AH. Adenoid tissues harboring S. pneumoniae according to conventional culture (n = 4) expressed significantly higher levels of IL-17A mRNA as compared with those harboring S. pneumoniae detected by multiplex PCR (n = 7) (d). †p < 0.1 according to the Chi-squred test; *p < 0.05 according to the Mann-Whitney U test.

Comparison mRNA expression in adenoid tissue harboring different colonizers showed no significant difference in IL-17A mRNA levels between children positive or negative for S. aureus, H. influenzae, or M. catarrhalis (Fig. 4) colonization (determined from the results of conventional culture).

Figure 4.

Figure 4

Open in a new tab

Comparison of IL-17A expression in adenoid tissue harboring different colonizers. There was no significant difference in IL-17A mRNA levels in adenoid tissue between children positive and negative for Staphylococcus aureus (n = 14 and 12, respectively) (a) Haemophilus influenzae (n = 11 and 15, respectively) (b) or (c) Moraxella cattarrhalis (n = 6 and 20, respectively) colonization (determined from the results of conventional culture). P-values were analyzed by the Mann–Whitney U test.

Western blot analysis of IL-17A

IL-17A levels in adenoid tissues from the 32 patients, measured by western blot, confirmed the results of mRNA analysis, showing that SDBwAH patients and those positive for pneumococcal carriage expressed higher levels of IL-17A relative to SDBsAH patients (Fig. 5a) and those negative for pneumococcal carriage (Fig. 5b) respectively.

Figure 5.

Figure 5

Open in a new tab

Protein quantification by western blot confirmed result of mRNA analysis, showing that adenoid tissue from SDBwAH patients and positive for pneumococcal carriage expressed higher levels of IL-17A than those from SDBsAH patients (a) and negative for pneumococcal carriage (b) respectively. The grouping of blots cropped from the same gel of the same patients. *p < 0.05 according to the Mann–Whitney U test.

Association studies

IL-17A mRNA levels were correlated with those of its transcription factors including RORγt and aryl hydrocarbon receptor (AhR) (Fig. 6a,b), whereas IL-10 levels were correlated with Foxp3 levels (Fig. 6c). Additionally, IL-17A levels were positively correlated with SDB patient age (Fig. 6d), which corresponded to our knowledge of that the pneumococcal carriage rate decreases with age. Furthermore, A:N ratio was positively correlated with OSA-18 symptom scores in SDBwAH patients (Fig. 6e), indicating the AH played a critical role in the severity of OSA.

Figure 6.

Figure 6

Open in a new tab

IL-17A mRNA expression was correlated with that of RORγt (a) and AhR (b). IL-10 mRNA expression was correlated with that of Foxp3 (c). IL-17A mRNA levels were positively correlated with the age of patients with SDB (d). The adenoid:nasopharynx (A:N) ratio was positively correlated with OSA-18 symptom scores in SDBwAH patients (e). Data were analyzed using Spearman’s correlation coefficient. *p < 0.05; **p < 0.01.

Discussion

This is the first study to evaluate IL-17A expression in adenoid tissue from children with SDB and its association with AH and pneumococcal carriage. The results revealed increased mRNA expression of IL-17A, IL-17:IL-10 ratio, and RORγt/Foxp3 ratio in adenoid tissues from SDBwAH patients and those positive for pneumococcal carriage as compared with that in SDBsAH patients and those negative for pneumococcal carriage. Additionally, IL-17A mRNA levels were correlated with those of its transcription factor RORγt, as well as that of AhR, and mRNA levels of IL-10, a cytokine associated with Treg cells, were correlated with those of its transcription factor Foxp3. Furthermore, pneumococcal carriage was more common in nasopharyngeal adenoids from SDBsAH patients as compared with those from SDBwAH patients. These results indicated that pneumococcal carriage might initiate IL-17A-mediated immune response in nasopharyngeal adenoids to eradicate colonization, and that this activity might be associated with AH in patients with SDB. Children with high levels of IL-l7A in response to pneumococcal carriage would likely exhibit an elevated ability to clear mucosal carriage; however, these children might also be susceptible to AH development due the activation of IL-17A-associated immune pathways.

Previous studies explored the role of Th17/Treg cells in pneumococcal carriage in the nasopharynx15,19–22. Pneumolysin, a protein toxin expressed by virtually all pneumococcal strains and considered an important virulence factor associated with invasive pneumococcal disease, reportedly activates Th17 cells in human nasopharynx-associated lymphoid tissue and that might be associated with mucosal clearance of pneumococcal carriage22. Jiang et al.20 reported that upregulation of Foxp3+ Treg cells might downregulate the production of Th17 cells in the adenoid, resulting in decreased scavenging of S. pneumoniae and chronic pneumococcal carriage. The balance between Th17 and Treg cells in the nasopharyngeal adenoid appears to be a major host factor closely associated with clearance of S. pneumoniae from the nasopharynx27. The present study directly investigated the expression of cytokines in adenoid tissue and revealed increased expression of IL-17A, as well an elevated IL-17A:IL-10 ratio, in adenoid tissues positive for pneumococcal carriage. Furthermore, adenoid tissues positive for S. pneumoniae according to conventional culture (either with or without PCR-positive results) expressed significantly higher levels of IL-17A mRNA relative to those with S. pneumoniae detected merely by multiplex PCR. Although only four patients were positive for pneumococcal culture, the difference was significant (p = 0.012). PCR is generally considered more sensitive than conventional culture in detecting the presence of S. pneumoniae. This implicated a lower density of pneumococcal carriage detected by multiplex PCR than those by conventional culture. As a consequence, the IL-17A expression in culture-positive patients was higher. Our findings implicated that the bacterial density of pneumococcal carriage corresponded to IL-17A expression; however, Hoe et al.28 reported a different result, revealing that a high density of pneumococcal nasopharyngeal carriage was associated with reduced IL-17 secretion in blood samples and isolated peripheral blood mononuclear cells, whereas low pneumococcal-carriage density was associated with increased IL-17 secretion in children. This might be because IL-17A could be important for controlling the inflammatory process under conditions of low pneumococcal-carriage density28 However, dysregulated or ineffective IL-17A responses might also provide a favorable environment to allow S. pneumoniae to survive in high-density environments, thereby leading to frequent or chronic infectious diseases. It is possible that the types of specimens collected, the patients cohort, the disease setting, and patient socio-economic status might have contributed to the differences observed between the studies. In the present study, we directly measured the expression of cytokines and the presence of pneumococcal carriage in adenoid tissue obtained during surgery on SDB patients. We believe that these results better reflect actual local immune response in the nasopharynx and might correlate better with carriage status.

Although IL-17A was first described as the signature cytokine of Th17 cells29, group 3 innate lymphoid cells (ILC3s) have recently emerged as key producers of IL-17A30,31. ILCs are prevalent at mucosal sites and play an important role in the defense of mucosal surfaces32. Three ILC groups that parallel CD4+ Th lymphocyte subsets have been proposed33,34 and include ILC3s, which also express RORγt and produce IL-17A and IL-22 in response to mucosal infection30. Therefore, ILC3 might play a central role in the early regulation of antimicrobial activity and inflammation at mucosal sites, such as the intestine and respiratory tract35. Lymphoid-tissue-inducer (LTi) cells are principal members of ILC3s and usually aggregate with stromal, dendritic, and B cells in cryptopatches, isolated lymphoid follicles, or mature isolated lymphoid follicles and are associated with lymphoid-tissue development36. Consequently, our results suggest that activation of the IL-17A-mediated immune response by pneumococcal carriage might also by related to the stimulation of LTi cells, resulting in hyperplasia of adenoid tissue. However, further studies involving adenoid cell profiling or co-staining for ILC3s and Th17 cells are necessary to clarify the main IL-17A producers in these samples.

Recent evidence implicated inflammatory cytokines in the onset and progression of pediatric SDB or OSAS based on the concurrence of chronic systemic inflammation37,38. Previous studies reported increases in proinflammatory cytokines, including C-reactive protein and IL-17, in pediatric OSAS patients39,40, and Huang et al. showed that children with OSAS present with elevated serum IL-17 levels that might contribute to complicated prognosis of pediatric OSAS41. Additionally, Ye et al.42 demonstrated significant increases in peripheral Th17-cell number, Th17-related cytokines (IL-17 and IL-6), and RORγt mRNA levels in severe OSAS cases42. Most previous studies investigated the expression of these inflammatory cytokines or their mediators in peripheral blood39–42. Ni et al.’s study showed that Th17/Treg imbalance in pediatric peripheral blood and adenoid tissues was associated with increased risk of developing AH and OSA43. In pediatric patients, AH is the common cause of SDB or OSAS in children2,8. In this study, we also found that the A:N ratio was positively correlated with OSA-18 symptom scores in SDBwAH patients in our study cohort. Subsequent measurement of IL-17A in adenoid tissues suggested its important role in the development of AH and SDB, thereby supporting previous findings of IL-17A involvement in SDB and OSAS severity.

Longitudinal carriage studies of pneumococcus showed that pneumococcal colonization of the upper respiratory tract is a dynamic process, with most children colonized serially with single or even multiple serotypes44. Each colonization event might persist from days to months, thereby providing opportunities for infection or serving as a reservoir for the spread of the pathogen within the community. Pneumococcal carriage is common in young children and decreases with age. Mubarak et al.27 demonstrated a dynamic relationship between Th17 and Treg cells in the human nasopharynx that evolves with age, with increased Th17-cell and decreased Treg-cell number possibly corresponding to diminished pneumococcal carriage. Figure 6d shows increase with age was associated with increase in IL-17A expression in adenoids (with and without pneumococcal carriage). This result indicates that IL-17A activity increases with age, leading to a decline in the pneumococcal carriage rate. This support its role in protecting against pneumococcal colonization.

Th17 cells also play an important role in S. aureus infection. However, their role in healthy carriers remains relatively unstudied45. The Th1/Th17 profile was most common among T cell clones responding to extracellular S. aureus antigens. However, a recent study46 suggested specific differential host-strain interactions in S. aureus. Th17 counts and IL-17 levels in response to stimulation with endogenous strains (strains that were carried by individuals) were significantly lower than those in response to stimulation with exogenous ones (strains not carried by the individuals). In the present study, there was no difference in the mRNA levels of IL-17A (Fig. 4), the IL-17A:IL-10 mRNA ratio, and the RORγt/Foxp3 mRNA ratio (data not shown) between children positive or negative for S. aureus colonization. Taken together, these findings suggest that colonized S. aureus (endogenous strains) may have low or no impact on the expression of IL-17A in healthy subjects. Furthermore, the co-colonization of S. aureus was found in six of 11 children with S. pneumoniae colonization and in eight of 15 children without S. pneumoniae colonization in this cohort. There was no difference in the frequency of the co-colonization of S. aureus between the two groups (p = 0.951 by Chi-Square analysis). Based on these results, we could omit the confounding effect of S. aureus.

SDB is common in the pediatric population and inked to impaired life quality, behavioral problems, and failure to thrive5,6. Nasopharyngeal carriage of S. pneumoniae is also prevalent in young children and associated with both local and invasive infection17,18. Therefore, defining the role of IL-17A and its associated immune pathway in AH and pneumococcal carriage is important to support the design, implementation, and tailoring of therapeutics for successfully treating and preventing these diseases. This study expands the understanding of the possible mechanisms associated with AH and pneumococcal carriage. Future novel therapeutics targeting the IL-17A-related inflammatory response or capable of modulating the function of Th17 cells might be beneficial for those with residual or recurrent SDB following adenoidectomy and tonsillectomy. Moreover, our findings will support the development of new strategies to prevent pneumococcal-related diseases, possibly through the use of a whole-cell pneumococcal vaccine47.

This study has several limitations that warrant consideration. First, the study was conducted in a relatively small number of children, and our results need to be confirmed in larger studies. Second, this study implicated an association between IL-17A-related immune response, pneumococcal carriage, and AH; further experimental study involving experimental stimulation or inhibition based on animal models will be necessary to clarify the causative relationships and associated mechanisms implied by our findings. Finally, long-term studies are needed to investigate the continuing impact of IL-17A activity on the clinical outcomes of patients with AH or pneumococcal carriage.

Conclusion

Here, we showed that IL-17A was upregulated in adenoid tissues derived from SDBwAH patients positive for pneumococcal carriage. Our findings indicated that pneumococcal carriage was more common in the nasopharyngeal adenoids of SDBsAH patients as compared with those with SDBwAH. These result suggested that pneumococcal carriage initiates an IL-17A-mediated immune response to eradicate S. pneumoniae colonization in nasopharyngeal adenoids, which might be associated with AH in patients with SDB. Future novel therapeutics targeting IL-17A-related immune responses might be beneficial for treating these diseases.

Electronic supplementary material

Supplementary information (458.8KB, pdf)

Acknowledgements

The authors received research grants from Chang Gung Memorial Hospital (CMRPG3G0061, and CMRPG3G0062).

Author Contributions

C.H. Chiu and C.C. Huang participated in study design. C.C. Huang performed and analyzed the experiments and wrote the manuscript. P.W. W.u. helped draft the manuscript. C.L. Liang and C.H. Wang contributed to the collection and selection of tissue samples and clinical data. T.J. Lee and C.N. Tsai contributed to the data interpretation. All authors participated in scientific discussion and approved the final manuscript.

Data Availability

All data described in the study are presented in the manuscript. The datasets analyzed are available from the corresponding author on reasonable request.

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Supplementary information accompanies this paper at 10.1038/s41598-018-35169-x.

References

  • 1.Mitchell RB, Pereira KD, Friedman NR. Sleep-disordered breathing in children: survey of current practice. Laryngoscope. 2006;116:956–958. doi: 10.1097/01.MLG.0000216413.22408.FD. [DOI] [PubMed] [Google Scholar]
  • 2.Kaditis AG, et al. Obstructive sleep disordered breathing in 2- to 18-year-old children: diagnosis and management. Eur Respir J. 2016;47:69–94. doi: 10.1183/13993003.00385-2015. [DOI] [PubMed] [Google Scholar]
  • 3.Marcus CL, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130:576–584. doi: 10.1542/peds.2012-1671. [DOI] [PubMed] [Google Scholar]
  • 4.Tauman R, et al. Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy. J Pediatr. 2006;149:803–808. doi: 10.1016/j.jpeds.2006.08.067. [DOI] [PubMed] [Google Scholar]
  • 5.Lal C, Strange C, Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest. 2012;141:1601–1610. doi: 10.1378/chest.11-2214. [DOI] [PubMed] [Google Scholar]
  • 6.Gozal D, et al. Neurocognitive and endothelial dysfunction in children with obstructive sleep apnea. Pediatrics. 2010;126:e1161–1167. doi: 10.1542/peds.2010-0688. [DOI] [PubMed] [Google Scholar]
  • 7.Chang SJ, Chae KY. Obstructive sleep apnea syndrome in children: Epidemiology, pathophysiology, diagnosis and sequelae. Korean J Pediatr. 2010;53:863–871. doi: 10.3345/kjp.2010.53.10.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Marcus CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368:2366–2376. doi: 10.1056/NEJMoa1215881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Alonso-Alvarez ML, et al. Treatment outcomes of obstructive sleep apnoea in obese community-dwelling children: the NANOS study. Eur Respir J. 2015;46:717–727. doi: 10.1183/09031936.00013815. [DOI] [PubMed] [Google Scholar]
  • 10.Kim SY, et al. Regrowth of the adenoids after coblation adenoidectomy: cephalometric analysis. Laryngoscope. 2013;123:2567–2572. doi: 10.1002/lary.23984. [DOI] [PubMed] [Google Scholar]
  • 11.Brandtzaeg P. Immune functions of nasopharyngeal lymphoid tissue. Adv Otorhinolaryngol. 2011;72:20–24. doi: 10.1159/000324588. [DOI] [PubMed] [Google Scholar]
  • 12.Brandtzaeg P. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am J Respir Crit Care Med. 2011;183:1595–1604. doi: 10.1164/rccm.201011-1783OC. [DOI] [PubMed] [Google Scholar]
  • 13.Morris MC, et al. Adenoidal follicular T helper cells provide stronger B-cell help than those from tonsils. Laryngoscope. 2016;126:E80–85. doi: 10.1002/lary.25536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hirahara K, et al. Helper T-cell differentiation and plasticity: insights from epigenetics. Immunology. 2011;134:235–245. doi: 10.1111/j.1365-2567.2011.03483.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhang Q, et al. Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLoS Pathog. 2011;7:e1002175. doi: 10.1371/journal.ppat.1002175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Arpaia N, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451–455. doi: 10.1038/nature12726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374:1543–1556. doi: 10.1016/S0140-6736(09)61114-4. [DOI] [PubMed] [Google Scholar]
  • 18.Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet. Infect. Dis. 2004;4:144–154. doi: 10.1016/S1473-3099(04)00938-7. [DOI] [PubMed] [Google Scholar]
  • 19.Jochems SP, Weiser JN, Malley R. The immunological mechanisms that control pneumococcal carriage. PLoS Pathog. 2017;21,13(12):e1006665. doi: 10.1371/journal.ppat.1006665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jiang XL, et al. Association of Pneumococcal Carriage and Expression of Foxp3+ Regulatory T Cells and Th17 Cells in the Adenoids of Children. Respiration. 2015;90:25–32. doi: 10.1159/000381724. [DOI] [PubMed] [Google Scholar]
  • 21.Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009;119:1899–1909. doi: 10.1172/JCI36731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Gray C, et al. Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage. Mucosal Immunol. 2014;7:705–717. doi: 10.1038/mi.2013.89. [DOI] [PubMed] [Google Scholar]
  • 23.Huang YS, et al. Clinical manifestations of pediatric obstructive sleep apnea syndrome: Clinical utility of the Chinese-version Obstructive Sleep Apnea Questionaire-18. Psychiatry Clin Neurosci. 2015;69:752–762. doi: 10.1111/pcn.12331. [DOI] [PubMed] [Google Scholar]
  • 24.Fujioka M, Young LW, Girdany BR. Radiographic evaluation of adenoidal size in children: adenoidal-nasopharyngeal ratio. AJR Am J Roentgenol. 1979;133:401–404. doi: 10.2214/ajr.133.3.401. [DOI] [PubMed] [Google Scholar]
  • 25.DeMuri GP, et al. Dynamics of bacterial colonization with Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory infection. Clin Infect Dis. 2018;19(66):1045–1053. doi: 10.1093/cid/cix941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Siira L, et al. From Quellung to multiplex PCR, and back when needed, in pneumococcal serotyping. J Clin Microbiol. 2012;50:2727–2731. doi: 10.1128/JCM.00689-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mubarak A, et al. A dynamic relationship between mucosal T helper type 17 and regulatory T-cell populations in nasopharynx evolves with age and associates with the clearance of pneumococcal carriage in humans. Clin Microbiol Infect. 2016;22:736.e1–7. doi: 10.1016/j.cmi.2016.05.017. [DOI] [PubMed] [Google Scholar]
  • 28.Hoe E, et al. Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children. PLoS One. 2015;10(6):e0129199. doi: 10.1371/journal.pone.0129199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Harrington LE, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005;6:1123–1132. doi: 10.1038/ni1254. [DOI] [PubMed] [Google Scholar]
  • 30.Melo-Gonzalez F, Hepworth MR. Functional and phenotypic heterogeneity of group 3 innate lymphoid cells. Immunology. 2017;150:265–275. doi: 10.1111/imm.12697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Klose CS, Artis D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol. 2016;17:765–774. doi: 10.1038/ni.3489. [DOI] [PubMed] [Google Scholar]
  • 32.Spits H, et al. Innate lymphoid cells—a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13:145–149. doi: 10.1038/nri3365. [DOI] [PubMed] [Google Scholar]
  • 33.Van Maele L, et al. Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. J Infect Dis. 2014;210(3):493–503. doi: 10.1093/infdis/jiu106. [DOI] [PubMed] [Google Scholar]
  • 34.Zook EC, Kee BL. Development of innate lymphoid cells. Nat Immunol. 2016;17(7):775–782. doi: 10.1038/ni.3481. [DOI] [PubMed] [Google Scholar]
  • 35.Bessman NJ, Sonnenberg GF. Emerging roles for antigen presentation in establishing host-microbiome symbiosis. Immunol Rev. 2016;272(1):139–150. doi: 10.1111/imr.12425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Montaldo E, Juelke K, Romagnani C. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice. Eur J Immunol. 2015;45(8):2171–2182. doi: 10.1002/eji.201545598. [DOI] [PubMed] [Google Scholar]
  • 37.Peppard PE, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–1384. doi: 10.1056/NEJM200005113421901. [DOI] [PubMed] [Google Scholar]
  • 38.Pai JK, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351:2599–2610. doi: 10.1056/NEJMoa040967. [DOI] [PubMed] [Google Scholar]
  • 39.Gozal D, et al. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med. 2007;176:188–193. doi: 10.1164/rccm.200610-1519OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Yokoe T, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129–1134. doi: 10.1161/01.CIR.0000052627.99976.18. [DOI] [PubMed] [Google Scholar]
  • 41.Huang YS, et al. Inflammatory cytokines in pediatric obstructive sleep apnea. Medicine (Baltimore). 2016;95(41):e4944. doi: 10.1097/MD.0000000000004944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ye J, et al. The treg/th17 imbalance in patients with obstructive sleep apnoea syndrome. Mediators Inflamm. 2012;2012:815308. doi: 10.1155/2012/815308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ni K, et al. Th17/Treg balance in children with obstructive sleep apnea syndrome and the relationship with allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2015;79:1448–1454. doi: 10.1016/j.ijporl.2015.06.026. [DOI] [PubMed] [Google Scholar]
  • 44.Syrjänen RK, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J. Infect. Dis. 2001;184:451–459. doi: 10.1086/322048. [DOI] [PubMed] [Google Scholar]
  • 45.Archer NK, Harro JM, Shirtliff ME. Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect Immun. 2013;81(6):2070–2075. doi: 10.1128/IAI.00084-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Reiss-Mandel, A. et al. Staphylococcus aureus Colonization Induces Strain-Specific Suppression of Interleukin-17. Infect Immun. Feb 20;86(3) (2018). [DOI] [PMC free article] [PubMed]
  • 47.Khan MN, Pichichero ME. The host immune dynamics of pneumococcal colonization: Implications for novel vaccine development. Human Vaccines & Immunotherapeutics. 2014;10(12):3688–3699. doi: 10.4161/21645515.2014.979631. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary information (458.8KB, pdf)

Data Availability Statement

All data described in the study are presented in the manuscript. The datasets analyzed are available from the corresponding author on reasonable request.

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES